FOXN3-AS1: A Candidate Prognostic Marker and Epigenetic Target with Immunotherapeutic Implications in Acute Myeloid Leukemia.
Sign Up to like & getrecommendations! Published in 2024 at "Current medicinal chemistry"
DOI: 10.2174/0109298673311108240926062214
Abstract: AIM We focused on the FOXN3 gene and selected its antisense transcripts (FOXN3-AS1) to investigate its potential involvement in acute myeloid leukemia (AML). BACKGROUND Several integrated multi-omics datasets have expanded the horizons of the cancer… read more here.
Keywords: foxn3; as1 expression; aml patients; foxn3 as1 ... See more keywords